Literature DB >> 1939006

In vitro movement of actin filaments on gizzard smooth muscle myosin: requirement of phosphorylation of myosin light chain and effects of tropomyosin and caldesmon.

T Okagaki1, S Higashi-Fujime, R Ishikawa, H Takano-Ohmuro, K Kohama.   

Abstract

ATP-dependent movement of actin filaments on smooth muscle myosin was investigated by using the in vitro motility assay method in which myosin was fixed on the surface of a coverslip in a phosphorylated or an unphosphorylated state. Actin filaments slid on gizzard myosin phosphorylated with myosin light chain kinase (MLCK) at a rate of 0.35 micron/s, but did not slide at all on unphosphorylated myosin. The movement of actin filaments on phosphorylated myosin was stopped by perfusion of phosphatase. Subsequent perfusion with a solution containing MLCK, calmodulin, and Ca2+ enabled actin filaments to move again. The sliding velocities on monophosphorylated and diphosphorylated myosin by MLCK were not different. Actin filaments did not move on myosin phosphorylated with protein kinase C (PKC). The sliding velocity on myosin phosphorylated with both MLCK and PKC was identical to that on myosin phosphorylated only with MLCK. Gizzard tropomyosin enhanced the sliding velocity to 0.76 micron/s. Gizzard caldesmon decreased the sliding velocity with increase in its concentration. At a 5-fold molar ratio of caldesmon to actin, the movement stopped completely. This inhibitory effect of caldesmon was relieved upon addition of excess calmodulin and Ca2+.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1939006     DOI: 10.1093/oxfordjournals.jbchem.a123471

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  18 in total

1.  Link between the enzymatic kinetics and mechanical behavior in an actomyosin motor.

Authors:  I Amitani; T Sakamoto; T Ando
Journal:  Biophys J       Date:  2001-01       Impact factor: 4.033

2.  The effects of caldesmon extraction on mechanical properties of skinned smooth muscle fibre preparations.

Authors:  U Malmqvist; A Arner; R Makuch; R Dabrowska
Journal:  Pflugers Arch       Date:  1996-06       Impact factor: 3.657

3.  Modulatory role of drebrin on the cytoskeleton within dendritic spines in the rat cerebral cortex.

Authors:  K Hayashi; R Ishikawa; L H Ye; X L He; K Takata; K Kohama; T Shirao
Journal:  J Neurosci       Date:  1996-11-15       Impact factor: 6.167

4.  Myosin light chain kinase from skeletal muscle regulates an ATP-dependent interaction between actin and myosin by binding to actin.

Authors:  K Fujita; L H Ye; M Sato; T Okagaki; Y Nagamachi; K Kohama
Journal:  Mol Cell Biochem       Date:  1999-01       Impact factor: 3.396

5.  Activation of MAP kinases and phosphorylation of caldesmon in canine colonic smooth muscle.

Authors:  W T Gerthoffer; I A Yamboliev; M Shearer; J Pohl; R Haynes; S Dang; K Sato; J R Sellers
Journal:  J Physiol       Date:  1996-09-15       Impact factor: 5.182

6.  Are actin filaments moving under unloaded conditions in the in vitro motility assay?

Authors:  J R Haeberle; M E Hemric
Journal:  Biophys J       Date:  1995-04       Impact factor: 4.033

7.  Movement of single myosin filaments and myosin step size on an actin filament suspended in solution by a laser trap.

Authors:  K Saito; T Aoki; T Aoki; T Yanagida
Journal:  Biophys J       Date:  1994-03       Impact factor: 4.033

8.  Three-dimensional image reconstruction of reconstituted smooth muscle thin filaments: effects of caldesmon.

Authors:  J L Hodgkinson; S B Marston; R Craig; P Vibert; W Lehman
Journal:  Biophys J       Date:  1997-06       Impact factor: 4.033

9.  Effect of unphosphorylated smooth muscle myosin on caldesmon-mediated regulation of actin filament velocity.

Authors:  K Y Horiuchi; S Chacko
Journal:  J Muscle Res Cell Motil       Date:  1995-02       Impact factor: 2.698

10.  Effects of a myosin light chain kinase inhibitor, wortmannin, on cytoplasmic Ca2+ levels, myosin light chain phosphorylation and force in vascular smooth muscle.

Authors:  M Takayama; H Ozaki; H Karaki
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-07       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.